102 related articles for article (PubMed ID: 16940045)
1. N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha3beta1 integrin-mediated cell migration.
Zhao Y; Nakagawa T; Itoh S; Inamori K; Isaji T; Kariya Y; Kondo A; Miyoshi E; Miyazaki K; Kawasaki N; Taniguchi N; Gu J
J Biol Chem; 2006 Oct; 281(43):32122-30. PubMed ID: 16940045
[TBL] [Abstract][Full Text] [Related]
2. The glycomic effect of N-acetylglucosaminyltransferase III overexpression in metastatic melanoma cells. GnT-III modifies highly branched N-glycans.
Link-Lenczowski P; Bubka M; Balog CIA; Koeleman CAM; Butters TD; Wuhrer M; Lityńska A
Glycoconj J; 2018 Apr; 35(2):217-231. PubMed ID: 29502191
[TBL] [Abstract][Full Text] [Related]
3. Remodeling of the major mouse xenoantigen, Galalpha1-3Galbeta1-4GlcNAc-R, by N-acetylglucosaminyltransferase-III.
Chung TW; Kim KS; Kang SK; Lee JW; Song EY; Chung TH; Yeom YI; Kim CH
Mol Cells; 2003 Dec; 16(3):343-53. PubMed ID: 14744025
[TBL] [Abstract][Full Text] [Related]
4. Reduction of the Gal-alpha1,3-Gal epitope of mouse endothelial cells by transfection with the N-acetylglucosaminyltransferase III gene.
Chung TW; Kim KS; Kim CH
Mol Cells; 2003 Dec; 16(3):368-76. PubMed ID: 14744028
[TBL] [Abstract][Full Text] [Related]
5. Targeting aberrant glycosylation to modulate microglial response and improve cognition in models of Alzheimer's disease.
Wang Y; Du Y; Huang H; Cao Y; Pan K; Zhou Y; He J; Yao W; Chen S; Gao X
Pharmacol Res; 2024 Apr; 202():107133. PubMed ID: 38458367
[TBL] [Abstract][Full Text] [Related]
6. Limited N-Glycan Processing Impacts Chaperone Expression Patterns, Cell Growth and Cell Invasiveness in Neuroblastoma.
Hall MK; Shajahan A; Burch AP; Hatchett CJ; Azadi P; Schwalbe RA
Biology (Basel); 2023 Feb; 12(2):. PubMed ID: 36829569
[TBL] [Abstract][Full Text] [Related]
7. Lewis X-carrying N-glycans regulate the proliferation of mouse embryonic neural stem cells via the Notch signaling pathway.
Yagi H; Saito T; Yanagisawa M; Yu RK; Kato K
J Biol Chem; 2012 Jul; 287(29):24356-64. PubMed ID: 22645129
[TBL] [Abstract][Full Text] [Related]
8. Targeting the ATF6-Mediated ER Stress Response and Autophagy Blocks Integrin-Driven Prostate Cancer Progression.
Macke AJ; Pachikov AN; Divita TE; Morris ME; LaGrange CA; Holzapfel MS; Kubyshkin AV; Zyablitskaya EY; Makalish TP; Eremenko SN; Qiu H; Riethoven JM; Hemstreet GP; Petrosyan A
Mol Cancer Res; 2023 Sep; 21(9):958-974. PubMed ID: 37314749
[TBL] [Abstract][Full Text] [Related]
9. Abnormal glycosylation in glioma: related changes in biology, biomarkers and targeted therapy.
Yue J; Huang R; Lan Z; Xiao B; Luo Z
Biomark Res; 2023 May; 11(1):54. PubMed ID: 37231524
[TBL] [Abstract][Full Text] [Related]
10. Regulation of neural stem cell differentiation and brain development by MGAT5-mediated N-glycosylation.
Yale AR; Kim E; Gutierrez B; Hanamoto JN; Lav NS; Nourse JL; Salvatus M; Hunt RF; Monuki ES; Flanagan LA
Stem Cell Reports; 2023 Jun; 18(6):1340-1354. PubMed ID: 37172586
[TBL] [Abstract][Full Text] [Related]
11. Roles of N-linked glycosylation and glycan-binding proteins in placentation: trophoblast infiltration, immunomodulation, angiogenesis, and pathophysiology.
Huang Z; Lai PF; Cocker ATH; Haslam SM; Dell A; Brady HJM; Johnson MR
Biochem Soc Trans; 2023 Apr; 51(2):639-653. PubMed ID: 36929183
[TBL] [Abstract][Full Text] [Related]
12. Aberrant N-glycosylation in cancer: MGAT5 and β1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression.
de-Souza-Ferreira M; Ferreira ÉE; de-Freitas-Junior JCM
Cell Oncol (Dordr); 2023 Jun; 46(3):481-501. PubMed ID: 36689079
[TBL] [Abstract][Full Text] [Related]
13. An insight into new glycotherapeutics in glial inflammation: Understanding the role of glycosylation in mitochondrial function and acute to the chronic phases of inflammation.
Patil V; Bohara R; Winter C; Kilcoyne M; McMahon S; Pandit A
CNS Neurosci Ther; 2023 Jan; 29(1):429-444. PubMed ID: 36377513
[TBL] [Abstract][Full Text] [Related]
14. N-linked glycoproteomic profiling in esophageal squamous cell carcinoma.
Liu QW; Ruan HJ; Chao WX; Li MX; Jiao YL; Ward DG; Gao SG; Qi YJ
World J Gastroenterol; 2022 Aug; 28(29):3869-3885. PubMed ID: 36157541
[TBL] [Abstract][Full Text] [Related]
15. Serum N-glycan profiling as a diagnostic biomarker for the identification of hepatitis B virus-associated hepatocellular carcinoma.
Guo L; Wan L; Hu Y; Huang H; He B; Wen Z
J Gastrointest Oncol; 2022 Feb; 13(1):344-354. PubMed ID: 35284106
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design of UDP-GlcNAc analogs as candidate GnT-V inhibitors.
Vibhute AM; Tanaka HN; Mishra SK; Osuka RF; Nagae M; Yonekawa C; Korekane H; Doerksen RJ; Ando H; Kizuka Y
Biochim Biophys Acta Gen Subj; 2022 Jun; 1866(6):130118. PubMed ID: 35248671
[TBL] [Abstract][Full Text] [Related]
17. Roles of Integrins in Gastrointestinal Cancer Metastasis.
Hou S; Wang J; Li W; Hao X; Hang Q
Front Mol Biosci; 2021; 8():708779. PubMed ID: 34869579
[TBL] [Abstract][Full Text] [Related]
18. Clinical importance of high-mannose, fucosylated, and complex N-glycans in breast cancer metastasis.
Ščupáková K; Adelaja OT; Balluff B; Ayyappan V; Tressler CM; Jenkinson NM; Claes BS; Bowman AP; Cimino-Mathews AM; White MJ; Argani P; Heeren RM; Glunde K
JCI Insight; 2021 Dec; 6(24):. PubMed ID: 34752419
[TBL] [Abstract][Full Text] [Related]
19. Peptide Sequence Mapping around Bisecting GlcNAc-Bearing
Ohkawa Y; Kizuka Y; Takata M; Nakano M; Ito E; Mishra SK; Akatsuka H; Harada Y; Taniguchi N
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445285
[No Abstract] [Full Text] [Related]
20. Bisecting GlcNAc modification diminishes the pro-metastatic functions of small extracellular vesicles from breast cancer cells.
Tan Z; Cao L; Wu Y; Wang B; Song Z; Yang J; Cheng L; Yang X; Zhou X; Dai Z; Li X; Guan F
J Extracell Vesicles; 2020 Oct; 10(1):e12005. PubMed ID: 33304474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
